Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives

Introduction and Purpose: Alzheimer’s disease is the most common cause of dementia, affecting millions of people worldwide and posing a significant challenge to modern medicine. This review explores the available treatment options, their limitations, and the future directions of research that ma...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Quality in Sport
المؤلفون الرئيسيون:	Adriana Skuba, Katarzyna Załuska, Agnieszka Świdniak, Marta Biskup, Aleksandra Bartoszek, Karolina Kopeć, Agnieszka Marut, Jagoda Misiuk, Julia Adamiuk, Sylwia Nykiel
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Nicolaus Copernicus University in Toruń 2025-05-01
الموضوعات:	Alzheimer's disease amyloid tau inflammation dementia acetylcho
الوصول للمادة أونلاين:	https://apcz.umk.pl/QS/article/view/58829

مواد مشابهة

Physical Exercise as a Therapeutic Strategy in Alzheimer’s Disease: Mechanisms and Benefits
حسب: Aleksandra Bartoszek, وآخرون
منشور في: (2025-05-01)

The Impact of Omega-3 Fatty Acids on the Onset and Management of Alzheimer's Disease
حسب: Marta Biskup, وآخرون
منشور في: (2025-05-01)

The Role of Omega-3 Fatty Acids in Cognitive Health: From Development to Aging and Neurodegenerative Protection
حسب: Julia Adamiuk, وآخرون
منشور في: (2025-05-01)

Testosterone therapy for hypoactive sexual desire disorder in women
حسب: Jagoda Misiuk Misiuk, وآخرون
منشور في: (2025-05-01)

HPV Vaccine: Current Data, Efficacy, and Clinical Implications
حسب: agnieszka marut, وآخرون
منشور في: (2025-05-01)

Penetration of heavy metals into breast milk and their impact on infant health - research analysis and literature review
حسب: Agnieszka Świdniak, وآخرون
منشور في: (2025-06-01)

The Medical Power of Capsaicin: Mechanisms, Applications, and Innovations
حسب: Katarzyna Załuska, وآخرون
منشور في: (2025-04-01)

The Dietary Fats: A Comprehensive Study about the Influence of Different Types of Fats on General Health and Developing Diseases
حسب: Sylwia Nykiel, وآخرون
منشور في: (2025-04-01)

Axial Spondyloarthritis in the Era of Precision Medicine: Biomarkers, Microbiota, and Multimodal Therapy
حسب: Karolina Kopeć, وآخرون
منشور في: (2025-03-01)

Using cerebrospinal fluid biomarkers to diagnose Alzheimer’s disease: an Australian perspective
حسب: Dhamidhu Eratne, وآخرون
منشور في: (2024-12-01)

Nasal lymphatic obstruction of CSF drainage as a possible cause of Alzheimer’s disease and dementia
حسب: William Thomas Phillips, وآخرون
منشور في: (2024-10-01)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
حسب: Alejandro R Roda, وآخرون
منشور في: (2022-01-01)

The need for better AD animal models
حسب: Miguel eMedina, وآخرون
منشور في: (2014-10-01)

Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition
حسب: Mattia Trunfio, وآخرون
منشور في: (2022-04-01)

Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
حسب: Matthias Pawlowski, وآخرون
منشور في: (2017-07-01)

Neurological Mechanisms of Animal-Assisted Intervention in Alzheimer’s Disease: A Hypothetical Review
حسب: Sujin Kim, وآخرون
منشور في: (2021-07-01)

Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
حسب: Kaden L. Nystuen, وآخرون
منشور في: (2024-01-01)

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
حسب: Yuanxin Zhao, وآخرون
منشور في: (2022-07-01)

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias
حسب: Adalberto Studart-Neto, وآخرون
منشور في: (2022-08-01)

Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
حسب: Minos Kritikos, وآخرون
منشور في: (2020-04-01)

Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
حسب: Sha Sha, وآخرون
منشور في: (2026-02-01)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
حسب: Daniel Lamontagne-Kam, وآخرون
منشور في: (2023-07-01)

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
حسب: Linda J. Van Eldik, وآخرون
منشور في: (2024-10-01)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
حسب: Yuehua Huang, وآخرون
منشور في: (2022-09-01)

Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
حسب: Mohammed Alrouji, وآخرون
منشور في: (2025-06-01)

The emerging double-edged sword role of exosomes in Alzheimer’s disease
حسب: Tao Liang, وآخرون
منشور في: (2023-06-01)

Dityrosine cross-linking and its potential roles in Alzheimer’s disease
حسب: Mahmoud B. Maina, وآخرون
منشور في: (2023-03-01)

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
حسب: Donovan A. McGrowder, وآخرون
منشور في: (2021-02-01)

Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
حسب: Eliasz Engelhardt, وآخرون
منشور في: (2024-12-01)

Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease
حسب: Javier Arranz, وآخرون
منشور في: (2024-06-01)

Panax ginseng: A modulator of amyloid, tau pathology, and cognitive function in Alzheimer's disease
حسب: Jaeuk Hwang, وآخرون
منشور في: (2025-07-01)

Amyloid-beta peptide toxicity in the aged brain is a one-way journey into Alzheimer’s disease
حسب: Georgia Culley, وآخرون
منشور في: (2025-04-01)

Curcuminoids and resveratrol as anti-Alzheimer agents
حسب: Oliver B. Villaflores, وآخرون
منشور في: (2012-12-01)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
حسب: Vasilios C. Constantinides, وآخرون
منشور في: (2023-02-01)

Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
حسب: Masahiro Hata, وآخرون
منشور في: (2025-01-01)

Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis
حسب: Zsolt Huszár, وآخرون
منشور في: (2024-04-01)

Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort
حسب: Eddy Roccati, وآخرون
منشور في: (2024-02-01)

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
حسب: Evgenia Salta, وآخرون
منشور في: (2016-08-01)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
حسب: Rola Ismail, وآخرون
منشور في: (2020-05-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
حسب: Hong-Qi Yang, وآخرون
منشور في: (2012-10-01)